GPP
INSM icon

Great Point Partners’s Insmed INSM Stock Holding History

Great Point Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-250,000
Closed -$16.8M – 34
2024
Q2 		$16.8M Sell
250,000
-525,585
-68% -$20.4M 3.21% 11
2024
Q1 		$21M Buy
775,585
+549,673
+243% +$15.4M 3.28% 12
2023
Q4 		$7M Sell
225,912
-168,960
-43% -$4.38M 1.19% 27
2023
Q3 		$9.97M Buy
+394,872
New +$9.03M 1.82% 27
2020
Q1 		– Sell
-97,359
Closed -$2.33M – 43
2019
Q4 		$2.33M Buy
+97,359
New +$1.98M 0.2% 34
2017
Q3 		– Sell
-538,473
Closed -$9.24M – 41
2017
Q2 		$9.24M Buy
+538,473
New +$9.2M 1.66% 21

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Great Point Partners's INSM Position: Q3 2024 in Review

Great Point Partners sold out of Insmed (INSM) in Q3 2024, closing a stake of 250,000 shares — an estimated $16.8M sold.

Great Point Partners first reported a position in INSM in Q2 2017 and held it in 6 quarters. The position peaked at $21M in Q1 2024. 413 funds tracked by Wall St. Rank hold INSM as of Q3 2024.

  • Great Point Partners reported no remaining Insmed position as of Q3 2024 after selling out during the quarter.
  • Great Point Partners sold 250,000 Insmed shares in Q3 2024, an estimated $16.8M.
  • Great Point Partners first reported a position in Insmed in Q2 2017 and held it in 6 quarters.
  • Great Point Partners's Insmed position peaked at $21M in Q1 2024.
  • 413 funds tracked by Wall St. Rank held Insmed as of Q3 2024.

Based on Great Point Partners's 13F filing for Q3 2024, filed 13 Nov 2024.